Baricitinib effective in cutaneous manifestations of dermatomyositis Dr Manoj Kumar Nayak30 Dec 2022 4:15 AM GMTBaricitinibeffective in cutaneous manifestations of dermatomyositisDermatomyositis(DM) is a rare autoimmune collagen vascular disease with cutaneous...
FIRST: Eli Lilly gets USFDA nod for alopecia areata pill Olumiant Ruchika Sharma14 Jun 2022 7:30 AM GMTOLUMIANT is a once-daily, oral JAK inhibitor discovered by Incyte and licensed to Lilly and is available through specialty pharmacies nationwide.
USFDA nod to Eli Lilly Olumiant for certain hospitalized Covid patients Ruchika Sharma13 May 2022 7:32 AM GMTOLUMIANT is a once-daily, oral JAK inhibitor discovered by Incyte and licensed to Lilly.
Trials BRAVE AA1 and BRAVE AA2 report Baricitinib to treat Alopecia Areata Dr. Nandita Mohan4 April 2022 11:30 AM GMTAlopecia areatai.e hair loss is a known autoimmune condition affecting the scalp, eyebrows, and eyelashes, for which treatments are limited....
Baricitinib, potential treatment option for refractory lichen planopilaris: JAAD Medha Baranwal1 April 2022 4:30 AM GMTAustralia: The addition of Baricitinib, a Janus kinase (JAK)-1/3 inhibitor, to concomitant treatment may be effective for treating recalcitrant lichen...
Baricitinib effects hair regrowth in severe Alopecia Areata: NEJM MD Editorial Team29 March 2022 5:30 AM GMTAlopecia areata is a known autoimmune condition characterized by rapid hair loss in the scalp, eyebrows, and eyelashes, for which treatments are...
WHO panel recommends Eli Lilly Baricitinib, GSK-Vir Biotechnology drug for COVID treatment Ruchika Sharma14 Jan 2022 10:29 AM GMTNew Delhi: The World Health Organization on Friday gave a nod to two new drugs for the treatment of COVID-19 patients with severe and non-severe...
Baricitinib Lowers Structural Joint Damage in Patients With RA: Study Dr. Shravani Dali7 Oct 2021 6:00 AM GMTBaricitinib helps to reduce structural joint damage in Patients With rheumatoid arthritis (RA), suggests a study published in the Journal of ...
Baricitinib and standard care combo may reduce mortality in hospitalized COVID-19 patients: Lancet Medha Baranwal6 Sep 2021 3:30 AM GMTUSA: The administration of the rheumatoid arthritis drug baricitinib, in combination with the standard of care including corticosteroids in...
Torrent Pharma net profit rises 2.8 percent to Rs 330 crore in Q1 Ruchika Sharma28 July 2021 4:30 AM GMTNew Delhi: Drug firm Torrent Pharmaceuticals on Tuesday reported a 2.8 percent rise in its consolidated net profit to Rs 330 crore for the quarter...
Dr Reddys expects volatile business growth in current fiscal Ruchika Sharma5 July 2021 7:12 AM GMTNew Delhi: Dr Reddy''s Laboratories expects its business growth to be "volatile" in the current fiscal as the coronavirus pandemic continues to bring...
Bajaj Healthcare moves patent office after Eli Lilly refuses to ink Baricitinib agreement Medical Dialogues Team28 Jun 2021 12:15 PM GMTNew Delhi: With Eli Lilly denying to ink voluntary licensing agreement for Baricitinib, Bajaj Healthcare Ltd (BHL) has approached the Indian patent...
